Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Business
Classified Sites

The Canadian Press - ONLINE EDITION

Biotech firm QLT deepens second-quarter loss as it paid to explore its options

The QLT Vancouver headquarters is pictured in a company handout photo. THE CANADIAN PRESS/HO, QLT

Enlarge Image

The QLT Vancouver headquarters is pictured in a company handout photo. THE CANADIAN PRESS/HO, QLT

VANCOUVER - Quarterly losses deepened at biotechnology firm QLT Inc. (TSX:QLT) as it booked higher expenses related to its merger with U.S.-based Auxilium Pharmaceuticals.

QLT reported a loss of US$8.6 million in the second quarter compared to $6.2 million a year ago.

Included in the results were $2.5 million in consulting and transaction expenses fees from the decision to explore its strategic alternatives earlier this year, which led to the agreement with Auxilium.

Losses per share for continuing operations were 17 cents versus 12 cents a year earlier.

Research and development costs grew to $4.1 million from $4.4 million.

In June, QLT signed a deal to merge with U.S.-based Auxilium that will see shareholders of the Canadian company owning about one quarter of the combined firm.

The combined organization will be led by Auxilium's current leadership team and will maintain Auxilium's current offices in Chesterbrook, Penn.

Visudyne, a treatment for a common form of age-related blindness, helped make QLT one of Canada's most successful biotechnology companies. However, sales of the drug collapsed after the introduction of Genentech's Lucentis and rising off-label use of cancer treatment Avastin.

Since then, the company has been selling off its products including Visudyne, which was bought by Valeant Pharmaceuticals International Inc. (TSX:VRX), and returning much of the proceeds to shareholders.

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
The First World War at 100

Social Media

Canadian Mortgage Rates